Tower Research Capital LLC (TRC) - KEMPHARM INC ownership

Quarter-by-quarter ownership
Tower Research Capital LLC (TRC) ownership history of KEMPHARM INC
ValueSharesWeighting
Q3 2023$19,897
+58.7%
4,128
+67.9%
0.00%
Q2 2023$12,541
+16847.3%
2,459
-84.7%
0.00%
-100.0%
Q4 2022$74
-99.8%
16,026
+165.3%
0.00%
+200.0%
Q3 2022$38,000
+35.7%
6,041
-3.7%
0.00%0.0%
Q2 2022$28,000
-80.3%
6,274
-77.8%
0.00%0.0%
Q1 2022$142,000
-6.0%
28,243
+62.8%
0.00%
-66.7%
Q4 2021$151,000
+619.0%
17,347
+688.1%
0.00%
+200.0%
Q3 2021$21,000
-12.5%
2,201
+15.5%
0.00%0.0%
Q2 2021$24,000
-96.0%
1,906
-97.1%
0.00%
-90.0%
Q1 2021$597,00064,9850.01%
Other shareholders
KEMPHARM INC shareholders Q4 2023
NameSharesValueWeighting ↓
SABBY MANAGEMENT, LLC 172,163$2,207,0000.31%
CVI Holdings, LLC 244,274$3,132,0000.21%
BOOTHBAY FUND MANAGEMENT, LLC 441,416$5,659,0000.18%
Hudson Bay Capital Management LP 723,076$9,270,0000.11%
Arete Wealth Advisors, LLC 56,401$723,0000.10%
Virtu Financial LLC 71,435$916,0000.09%
Kovack Advisors, Inc. 60,379$774,0000.09%
Pinz Capital Management, LP 10,500$135,0000.04%
Pensionmark Financial Group, LLC 13,350$171,0000.04%
Engineers Gate Manager LP 38,800$497,0000.03%
View complete list of KEMPHARM INC shareholders